CJC-1295 with DAC and TB-500 (Ac-LKKTETQ) Interaction

Synergistic
Mechanism-based 47% confidence

CJC-1295 with DAC and TB-500 (Ac-LKKTETQ) have a synergistic interaction with 47% confidence. CJC-1295 with DAC and TB-500 (Ac-LKKTETQ) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

Half-life: 6-8 days Typical dose: 1-2mg weekly growth hormone, weight loss
ghrh receptorigf1 carcinogenic riskestrogenicinsulin disrupting
View full profile

TB-500 (Ac-LKKTETQ)

Thymosin Beta-4 Active Fragment | Healing Peptide

TB-500 contains the LKKTETQ sequence which is the actin-binding motif of full-length thymosin beta-4. This fragment shares many properties of the parent protein regarding cell proliferation, differentiation, and migration.

Half-life: Not precisely established; effects persist longer than 24 hours Typical dose: 2-2.5mg per injection healing, longevity
vegf teratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Blood Vessels
low

Frequently Asked Questions

Can I take CJC-1295 with DAC with TB-500 (Ac-LKKTETQ)?

Yes, CJC-1295 with DAC and TB-500 (Ac-LKKTETQ) can generally be taken together. CJC-1295 with DAC and TB-500 (Ac-LKKTETQ) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is CJC-1295 with DAC and TB-500 (Ac-LKKTETQ) safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between CJC-1295 with DAC and TB-500 (Ac-LKKTETQ)?

CJC-1295 with DAC and TB-500 (Ac-LKKTETQ) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 with DAC and TB-500 (Ac-LKKTETQ)?

CJC-1295 with DAC has a half-life of 6-8 days and TB-500 (Ac-LKKTETQ) has a half-life of Not precisely established; effects persist longer than 24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 with DAC vs TB-500 (Ac-LKKTETQ)

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.